United States; Washington District of Columbia United States; Americas; North America; Northwest; DC Metro
Is it you?
Investor info
TypeAngel Investors / HNWStage focus
Seed Round
Description
Myla Lai-Guldman is an angel investor. Myla is currently a Co-Founder and Chair at GeneCentric Therapeutics, Inc., a firm based in District of Columbia, United States. Areas of interest include lung cancer diagnostics & hypoxia signature.